Clinical Research Advisories for Pharma Companies, CROs and Biotech's

Effective advisories are critical for the success of a pharmaceutical company and its products.

SRS provides strategy and consulting services in the sarcoma field for a wide range of functions of pharma industries, CROs and biotech’s, including recognized expert opinion on different sarcoma subtypes (clinical behavior, prognosis, therapeutic approaches, biomarkers, etc), clinical trial design, statistics, regulatory affairs and all the relative to clinical research. This expert opinion derives from almost 30 years of experience in sarcoma care and 20 years also in sarcoma research. Additionally, our own investigations also give us a relevant background for advising.

Engagement between medical community and pharmaceutical, via SRS, is an easy and valuable tool to obtain expert input throughout the entire drug development program, in addition to identifying other unmet medical needs that might drive novel clinical strategies in the future. SRS and their consultants brings deep, functional expertise in each one of these areas with the aim to optimize the sum of all the parts. Guided by Dr. Javier Martín Broto, Sarcoma Oncologist.

SRS help to provide advisory for:

1. Drug development and therapeutic applications

2. Risk management plans

3. Market strategy

4. Identification of knowledge gaps in specific therapeutic areas and to suggest actions that could be implemented and followed to link the identified gaps

5. Clinical trial design and protocol elaboration

6. Interpretation of clinical trial outcomes.

* Includes: Rationale; primary and secondary objective; statistical design and sample size calculation; statistical plan, inclusion and exclusion criteria; translational and preclinical research program.

Service Order Form

< Back